We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+24.55%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$8.79B
AUM Growth
+$1.45B
Cap. Flow
-$72.5M
Cap. Flow %
-0.82%
Top 10 Hldgs %
20.48%
Holding
2,420
New
180
Increased
1,163
Reduced
213
Closed
125

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$8.64M
2
WORK
Slack Technologies, Inc.
WORK
+$7.6M
3
ABBV icon
AbbVie
ABBV
+$7.02M
4
TMUS icon
T-Mobile US
TMUS
+$6.46M
5
OTIS icon
Otis Worldwide
OTIS
+$5.52M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$143M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$19M
3
AGN
Allergan plc
AGN
+$15M
4
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$13.8M
5
MUB icon
iShares National Muni Bond ETF
MUB
+$10.6M

Sector Composition

Rank Sector Weight
1 Technology 21.58%
2 Healthcare 14.02%
3 Financials 12.88%
4 Consumer Discretionary 10.4%
5 Industrials 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SYRE icon
1951
Spyre Therapeutics
SYRE
$9.18B
$186K ﹤0.01%
+805
New +$153K
PASG icon
1952
Passage Bio
PASG
$14.8M
$186K ﹤0.01%
+341
New +$153K
STOK icon
1953
Stoke Therapeutics
STOK
$2.13B
$186K ﹤0.01%
7,812
– –
BSTC
1954
DELISTED
BioSpecifics Technologies Corp.
BSTC
$186K ﹤0.01%
3,035
– –
GTS
1955
DELISTED
Triple-S Management Corporation
GTS
$186K ﹤0.01%
9,765
– –
BEAM icon
1956
Beam Therapeutics
BEAM
$2.76B
$185K ﹤0.01%
6,621
– –
INSW icon
1957
International Seaways
INSW
$4.58B
$185K ﹤0.01%
11,332
+1,726
+18% +$37.5K
HTBK
1958
DELISTED
Heritage Commerce
HTBK
$184K ﹤0.01%
24,561
– –
HLIT icon
1959
Harmonic Inc
HLIT
$1.3B
$184K ﹤0.01%
38,803
– –
SYRS
1960
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$184K ﹤0.01%
1,729
– –
MCFT icon
1961
MasterCraft Boat Holdings
MCFT
$600M
$184K ﹤0.01%
+9,656
New +$122K
GPRE icon
1962
Green Plains
GPRE
$1.06B
$183K ﹤0.01%
17,956
– –
HZO icon
1963
MarineMax
HZO
$1.15B
$183K ﹤0.01%
8,159
– –
RDUS
1964
DELISTED
Radius Recycling
RDUS
$183K ﹤0.01%
10,351
– –
ANDE icon
1965
Andersons Inc
ANDE
$2.23B
$182K ﹤0.01%
13,251
– –
ANGO icon
1966
AngioDynamics
ANGO
$651M
$182K ﹤0.01%
17,852
– –
GRPN icon
1967
Groupon
GRPN
$901M
$181K ﹤0.01%
9,992
+5,635
+129% +$125K
PEBO icon
1968
Peoples Bancorp
PEBO
$1.48B
$180K ﹤0.01%
8,443
– –
TSC
1969
DELISTED
TriState Capital Holdings, Inc.
TSC
$179K ﹤0.01%
11,422
– –
MCRI icon
1970
Monarch Casino & Resort
MCRI
$2.22B
$179K ﹤0.01%
5,265
– –
MORF
1971
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$179K ﹤0.01%
+6,630
New +$124K
FOR icon
1972
Forestar Group
FOR
$1.49B
$179K ﹤0.01%
11,875
+5,902
+99% +$81.3K
DBI icon
1973
Designer Brands
DBI
$311M
$179K ﹤0.01%
26,445
– –
BBSI icon
1974
Barrett Business Services
BBSI
$756M
$178K ﹤0.01%
13,432
– –
UTMD icon
1975
Utah Medical Products
UTMD
$230M
$177K ﹤0.01%
2,002
– –
77 78
79
80 81

Similar funds

SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BG
Bahl & Gaynor Cincinnati, Ohio $19.8B AUM 19.53% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

MetLife Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, MetLife Investment Management held 2,420 positions worth $8.79B, up 20% from $7.34B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

MetLife Investment Management's Q2 2020 filing shows 180 new, 1,163 increased, 213 reduced and 125 closed positions. Its largest new stake was DexCom: 96,564 shares worth $9.79M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $143M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q2 2020 buy was DexCom: 96,564 shares worth $9.79M.
  • MetLife Investment Management added most to AbbVie in Q2 2020, an estimated $7.02M increase.
  • MetLife Investment Management's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $143M.
  • MetLife Investment Management fully exited Allergan plc in Q2 2020, selling an estimated $15M.
  • MetLife Investment Management's ten largest holdings make up 20% of its $8.79B portfolio in Q2 2020.
  • MetLife Investment Management opened 180 new positions and closed 125 in Q2 2020.
  • MetLife Investment Management's portfolio value rose 20% quarter-over-quarter to $8.79B.

Based on MetLife Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.